Newsletter | August 5, 2025

08.05.25 -- A Guide To Designing mRNA Medicines

FEATURED EDITORIAL

A Guide To Designing mRNA Medicines

A poorly designed mRNA sequence can create ongoing difficulties during downstream clinical development and manufacture. Let's take a closer look at strategies and design software that you can employ.

INDUSTRY INSIGHTS

Rapid A BioSMB Biolayer Interferometry Technology

Monoclonal antibodies are crucial for treating severe diseases. Explore dynamic loading in continuous multi-column chromatography and the growing market due to high specificity and fewer side effects.

Innovative AI-Driven Solutions To Address The Growing Complexity Of APIs

Computer-aided synthesis planning (CASP) can mitigate the impact of rising complexity. Here, we discuss the award-winning AI and vast data that propel a leading predictive retrosynthesis technology.

Accelerating Clinical Development: Modern Tools In Process Chemistry

Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

Innovative Surgical Solutions: Safety Assessment Studies

Delve into the innovative techniques our surgical experts use to support toxicology and safety pharmacology studies, including dose development and procedures.

Consider Two Factors To Choose A CDMO For Developing Injectable Medicines

Explore agile, expert CDMO services for injectable medicines, combining technical excellence and near-term availability to accelerate development and manufacturing for biopharma companies.

SOLUTIONS

Cambrex Capacity Update April 2025: Analytical Services